Boglione-Kerrien C, Lemaitre F, Gautier-Veyret E, Baklouti S, et al. Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole? J Antimicrob Chemother 2026;81:dkag231.
PMID: 42483980